Please provide your email address to receive an email when new articles are posted on . The FDA announced that Teleflex and Arrow International LLC are recalling both the Arrow MAC Two-Lumen Central ...
BD (NYSE:BDX) today announced the commercial launch of its CentroVena One insertion system, a central venous catheter (CVC) insertion device.
Warren Buffett, the US financier, famously said, “cost is what you pay, value is what you get.” The clinical study by Weisen et al 1 associated with our editorial puts a spotlight on the highly ...
FDA continues to make use of its breakthrough device designation program, which was created in response to the 21st Century Cures Act and replaces the agency's previous expedited access pathway and ...
A pharmacogenetic study in rectal cancer patients treated with preoperative chemoradiotherapy based on capecitabine: Polymorphisms in thymidilyate synthase and DNA repair genes. This is an ASCO ...
NEW YORK & MUNICH--(BUSINESS WIRE)--Venock announced today it has successfully completed the demonstration of safety and efficacy of its large bore closure system in animal studies. Venock is ...
BEDFORD, Mass.--(BUSINESS WIRE)--Access Vascular, Inc., a company addressing the most common and costly venous access complications, today announced it has closed on a Series B round of financing. TVM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results